A clinical trial amongst Chinese patients revealed enolase 1 protein levels in tumor tissues and circulating plasma samples of NSCLC patients to be increased to suggest this glycolytic enzyme to be of diagnostic utility [39]. Here, ENO1 is linked to non-small cell lung carcinoma.